전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,132 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleGuangzhou Bio-gene Technology C…Phase 2

CD19 CAR-T cell infusion (CD19 CAR-T cell infusion)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

CD19 CAR-T cells and CD19 positive feeder T cells (CD19 CAR-T cells and CD19 positive feeder T cells)

Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Preclinical

CD19 CAR-T cells infusion (CD19 CAR-T cells infusion)

Non Hodgkin Lymphoma · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

CD19 CAR-T cells with CRS suppression technology (CD19 CAR-T cells with CRS suppression technology)

Acute Lymphoblastic Leukemia; CD19 Positive · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CD19 CARvac T cells (CD19 CARvac T cells)

B Cell Lymphoma; B Cell Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleUniversity of Colorado, DenverPhase 1

CD19 Directed CAR T Cell (CD19 Directed CAR T Cell)

Acute Lymphoid Leukemia; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

CD19 Universal CAR-T cells (CD19 Universal CAR-T cells)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 2

CD19 and CD22 targeted prime CAR-T cells (CD19 and CD22 targeted prime CAR-T cells)

B-ALL · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleXuanwu Hospital, BeijingPhase 2

CD19 hsCAR-T (CD19 hsCAR-T)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleNanjing Bioheng Biotech Co., Lt…Phase 1

CD19 or CD19-BCMA CAR-T (CD19 or CD19-BCMA CAR-T)

SLE (Systemic Lupus); Systemic Sclerosis · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSouthwest Hospital, ChinaPhase 2

CD19 or CD20 CAR T cells briging HSCT (CD19 or CD20 CAR T cells briging HSCT)

Lymphoma, Large B-Cell, Diffuse; Leukemia, Lymphocytic, Chronic, B-Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleH. Lee Moffitt Cancer Center an…Phase 2

CD19 targeted CAR T Cell Therapy (CD19 targeted CAR T Cell Therapy)

Diffuse Large-Cell Lymphoma; Primary Mediastinal Large B-Cell Lymphoma (PMBCL) · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleHebei Taihe Chunyu Biotechnolog…Phase 2

CD19&CD22 bispecific CAR-T cells (CD19&CD22 bispecific CAR-T cells)

B-Cell Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSt. Jude Children's Research Ho…Phase 2

SJCAR19 product (CD19- specific CAR engineered autologous T-cells, CD19- specific CAR engineered autologous T-cells (SJCAR19 product))

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleNingbo No. 1 HospitalPhase 1

CD19-7×19 CAR-T combined with Tislelizumab (CD19-7×19 CAR-T combined with Tislelizumab)

Diffuse Large B-cell Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

CD19-BCMA CAR-T cells infusion (CD19-BCMA CAR-T cells infusion)

Refractory Lupus Nephritis; Systemic Sclerosis · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleChang YingjunPhase 2

CD19-BCMA dual nanobody based CAR-T Cells (CD19-BCMA dual nanobody based CAR-T Cells)

Transplantation Candidates With Hematological Diseases · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

CD19-CAR novel oncolytic vaccinia virus (CD19-CAR novel oncolytic vaccinia virus)

Refractory/Relapsed B-cell Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleSt. Jude Children's Research Ho…Phase 1

CD19-CAR (Mem, CD19-CAR, CD19-CAR(Mem) T-cells)

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing JD Biotech Co. LTD.Phase 1

CD19-CAR-NK (CD19-CAR-NK)

Adult Relapsed/Refractory B-cell Hematologic Malignancies · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active

30 / 57 pages

← PreviousNext →